1.Anesthetic Experience of Dynamic Cardiomyoplasty: A case report.
Jin Hyung KWON ; Do Hyun KWON ; Young Rae CHO
Korean Journal of Anesthesiology 1997;33(1):162-166
Dynamic cardiomyoplasty is a recently introduced surgical method to improve myocardial performance. It consists of a placement of a skeletal muscle flap around the heart and stimulation of the flap in synchrony with ventricular contraction. We experienced a case of cardiomyoplasty in a 25 year old male patient with congestive heart failure. Anesthesia was induced and maintained with fentanyl, midazolam and isoflurane. The operation was performed for 8hrs without cardiopulmonary bypass and the patient was transferred to the intensive care unit. He was mechanically ventilated electively overnight and extubation was done 18hrs postoperatively. The patient was discharged home on the 40days after operation and improved in exercise tolerance. We report the anesthetic management and hemodynamic changes in a patient who underwent dynamic cardiomyoplasty.
Adult
;
Anesthesia
;
Cardiomyoplasty*
;
Cardiopulmonary Bypass
;
Exercise Tolerance
;
Fentanyl
;
Heart
;
Heart Failure
;
Hemodynamics
;
Humans
;
Intensive Care Units
;
Isoflurane
;
Male
;
Midazolam
;
Muscle, Skeletal
2.Anesthesia for Coronary Artery Bypass Grafting without Extracorporeal Circulation: One case report.
Jin Hyung KWON ; Keun Seok MO ; Young Rae CHO
Korean Journal of Anesthesiology 1997;33(2):381-384
Coronary artery bypass grafting (CABG) without extracorporeal circulation (ECC) is now an accepted technique of myocardial revascularization in selective cases of coronary arterial occlusive disease. We experienced a case of CABG without ECC in a 20 year old female patient with complete occlusion of the right coronary artery. Anesthesia was induced and maintained with fentanyl, midazolam and isoflurane. Nitroglycerine and dopamine were given to stabilize the hemodynamics during intra- and post-operative periods. And esmolol was administered with a loading dose of 30 mg over 1 min, followed by a continuous infusion of 50~100 g/kg/min to maintain the heart rate (50~60 beats/min) and systolic blood pressure (60~80 mmHg) during distal anastomosis. The patient was recovered uneventfully and discharged on the 8th postoperative day.
Anesthesia*
;
Arterial Occlusive Diseases
;
Blood Pressure
;
Coronary Artery Bypass*
;
Coronary Vessels*
;
Dopamine
;
Extracorporeal Circulation
;
Female
;
Fentanyl
;
Heart Rate
;
Hemodynamics
;
Humans
;
Isoflurane
;
Midazolam
;
Myocardial Revascularization
;
Nitroglycerin
;
Young Adult
3.Anesthesia for Heart Transplantation in a Jehovah,s Witness: A case report.
Jin Hyung KWON ; Do Hyun KWON ; Young Rae CHO
Korean Journal of Anesthesiology 1997;32(6):1023-1027
Jehovah,s Witnesses who require operation represent a challenge to the physician because of the patient,s refusal to accept blood transfusion. An orthotopic heart transplantation was succesfully performed in a 40-year old Jehovah,s Witness without use of any blood product. During the operation, cell saver was used for shed blood and aprotinin was administered intravenously. The use of blood conserving methods, meticulous operative technique and brisk postoperative diuresis has added to the efficacy of heart transplantation in this patient. Total postoperative drainage was 860 ml and the lowest hemoglobin level was 11.8 g%. The patient recovered uneventfully and discharged on the 60th postoperative day.
Adult
;
Anesthesia*
;
Aprotinin
;
Blood Transfusion
;
Disulfiram
;
Diuresis
;
Drainage
;
Heart Transplantation*
;
Heart*
;
Humans
;
Transplantation
4.Osteoclast-like Giant Cell Tumor of the Parotid Gland Accompanied with Carcinoma ex Pleomorphic Adenoma.
Mi Jung KWON ; Eun Sook NAM ; Seong Jin CHO ; Hyung Sik SHIN ; Ji Hyun KWON ; Young Soo RHO
Korean Journal of Pathology 2011;45(Suppl 1):S84-S88
The origin of osteoclast-like giant cell tumor (OGCT) of the salivary gland has been debated because the prototypic cells of osteoclast-like cells and mononuclear stromal cells are largely unexplained in this gland. Bone marrow-derived CD14+ and CD45+ monocyte-derived multipotential cells (CD14+/CD45+ MOMC) may be one of the possible origins of OGCTs of salivary glands, which have never been explored in salivary OGCTs. We present a case of OGCT accompanied with carcinoma ex pleomorphic adenoma in the parotid gland of a 67-year-old Korean female. The tumor presented as a rapidly growing cervical mass comprising a central area of carcinoma ex pleomorphic adenoma and a peripheral circumferential area of OGCT. The immunohistochemical staining pattern was phenotypically consistent with bone marrow-derived CD14+/CD45+ MOMC. This case is the first report of a salivary OGCT in Korea.
Adenoma, Pleomorphic
;
Aged
;
Cytosine
;
Female
;
Giant Cell Tumors
;
Giant Cells
;
Humans
;
Korea
;
Mixed Tumor, Malignant
;
Monocytes
;
Osteoclasts
;
Parotid Gland
;
Salivary Glands
;
Stromal Cells
5.Osteoclast-like Giant Cell Tumor of the Parotid Gland Accompanied with Carcinoma ex Pleomorphic Adenoma.
Mi Jung KWON ; Eun Sook NAM ; Seong Jin CHO ; Hyung Sik SHIN ; Ji Hyun KWON ; Young Soo RHO
Korean Journal of Pathology 2011;45(Suppl 1):S84-S88
The origin of osteoclast-like giant cell tumor (OGCT) of the salivary gland has been debated because the prototypic cells of osteoclast-like cells and mononuclear stromal cells are largely unexplained in this gland. Bone marrow-derived CD14+ and CD45+ monocyte-derived multipotential cells (CD14+/CD45+ MOMC) may be one of the possible origins of OGCTs of salivary glands, which have never been explored in salivary OGCTs. We present a case of OGCT accompanied with carcinoma ex pleomorphic adenoma in the parotid gland of a 67-year-old Korean female. The tumor presented as a rapidly growing cervical mass comprising a central area of carcinoma ex pleomorphic adenoma and a peripheral circumferential area of OGCT. The immunohistochemical staining pattern was phenotypically consistent with bone marrow-derived CD14+/CD45+ MOMC. This case is the first report of a salivary OGCT in Korea.
Adenoma, Pleomorphic
;
Aged
;
Cytosine
;
Female
;
Giant Cell Tumors
;
Giant Cells
;
Humans
;
Korea
;
Mixed Tumor, Malignant
;
Monocytes
;
Osteoclasts
;
Parotid Gland
;
Salivary Glands
;
Stromal Cells
6.The Atherogenic Index of Plasma is Associated With Cerebral Small Vessel Disease: A Cross-Sectional Study
Ki-Woong NAM ; Hyung-Min KWON ; Jin-Ho PARK ; Hyuktae KWON
Journal of Lipid and Atherosclerosis 2022;11(3):262-271
Objective:
Recently, the lipid profile of atherogenic dyslipidemia has become important in cerebrovascular diseases. Atherogenic index of plasma (AIP), an index that reflects this lipid profile as a single number, has been proposed, but there are still few related studies in cerebrovascular disease. In this study, we evaluated the relationship between AIP and cerebral small vessel disease (cSVD) in health check-up participants.
Methods:
We assessed consecutive health check-ups participants between 2006 and 2013. cSVD was measured including the following three subtypes: white matter hyperintensity (WMH), lacuens, and cerebral microbleeds (CMBs). WMH quantitatively measured the volume, and lacunes and CMBs qualitatively evaluated the presence. AIP was calculated according to the following formula based on blood test results: AIP=log [triglyceride (mg/ dL)/high-density lipoprotein cholesterol (mg/dL)].
Results:
A total of 3,170 participants were evaluated (mean age: 56.5 years, male sex: 53.8%). In multivariable linear regression analysis, AIP (β=0.129, 95% confidence interval [CI]=0.003–0.255) was associated with WMH. Age, hypertension, diabetes, lipid-lowering agents, and intracranial atherosclerosis were also associated with WMH volume. In multivariable logistic regression analysis, AIP (adjusted odds ratio=1.72 1.79, 95% CI=1.03– 2.90) showed close association with lacunes. Age and intracranial atherosclerosis were also related to lacunes. CMBs did not show a statistically significant association with AIP.
Conclusion
High AIP was associated with cSVD in health check-up participants. Since this close relationship was only seen in WMH and lacunes, these subtypes may have arisen from a more atherosclerosis-related pathology.
7.Optic Disc Hamartoma Combined with Optic Neuritis.
Jin Hyung KIM ; Hyoung Jun KOH ; Oh Woong KWON
Journal of the Korean Ophthalmological Society 2001;42(6):911-915
PURPOSE: Optic disc harmatoma is usually seen in tuberous sclerosis patients, but, it may be seen in otherwise normal people. Visual acuity is usually not affected by this lesion. METHODS: We experienced a 40-year-old woman with optic disc hamartoma who presented with acute visual defect. With oral triamcinolone 48mg/day, her visions recovered to normal in 2 weeks. RESULTS: Her age, symptom, and course of disease supported the diagnosis of optic neuritis. CONCLUSION: We report this patient as a case of optic disc hamartoma combined with optic neuritis.
Adult
;
Diagnosis
;
Female
;
Hamartoma*
;
Humans
;
Optic Neuritis*
;
Triamcinolone
;
Tuberous Sclerosis
;
Visual Acuity
8.Linear Scleroderma Clinically Improved with Cyclosporine.
Su Jin OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(6):487-489
No abstract available.
Cyclosporine*
;
Scleroderma, Localized*
9.Linear Scleroderma Clinically Improved with Cyclosporine.
Su Jin OH ; Hyung Kwon PARK ; Young Gyun KIM ; Joung Soo KIM ; Hee Joon YU
Korean Journal of Dermatology 2016;54(6):487-489
No abstract available.
Cyclosporine*
;
Scleroderma, Localized*
10.Cardiovascular Responses of General Anesthesia with Nalbuphine - Diazepam - O2 - 1/2 MAC Halothane and Awareness during Operation for Adult Open Heart Surgery.
Hyun Soo MOON ; Jin Hyung KWON ; Sang Min LEE
Korean Journal of Anesthesiology 1992;25(3):547-552
Recently, nalbuphine has been used for reversal of opioid indueed respiratory depression. Because of its structural chsracter, nalbuphine has been known as a better nareotic antagonist with keeping analgesic potency and without considerable cardiovascular responses. Some investigators reported nalbuphine can decrease minimum alveolar concentration(MAC) of major inhalation anesthetic agents and can be a intravenous anesthetic adjuvant but can accompany several adverse reactions such as hypertension and tachycardia etc. To evaluate the eligibility and efficacy of nalbuphine as a intravenous narcotic adjuvant for cardiac anesthesia, we selected 24 adult cardiac patients and divided them into 3 groups. Valvular surgerys were performed for group I patients, aorto-coronary-bypass surgerys(CABG) for group II and correction of congenital heart disease for group III, respectively, All patients were inducted general anesthesia with 0.3 mg/kg nalbuphine+0.1 mg/kg diazepam+2 mg/kg thio- pental sodium and maintained with intermittent injection of 0.3-0.5 mg/kg nalbuphine and O.l mg/kg diazepam just before the time of most stressful surgical stimuli with 1/2 MAC halothane inhalation under vecuronization for muscle relaxation. We measured heart rate(HR), systolic blood pressure(BP), central venous pressure(CVP) at pre-induction as a control data, and just after endotracheal intubation, skin incision, sternotomy, and skin closure respectively to compare basic cardiovascular responses of patients at surgical stimuli with control data. We also checked recovery time of consciousness and presence of awareness during operation. The results were as follows: 1) Significant HR changes occurred in group I at just after intubation time from 104+/-18.6 to 134+/-25.9 and in group II from 83+/-10.5 to 115+/-32.3 respectively. 2) There were few significant changes of systolic blood pressure during anesthesia of all groups except just after intubation in group II from 135+/-32.8 torr to 168+/-37.9 torr.3) A significant CVP decrease occurred only in group I at the time of skin closure from 13+/-3. 5 cmHO to 10+/-3.8 cmH2O because of operative correction of tricuspid regurgitation of group I patients rather than anesthesia effects. 4) Recovery of consciousness needed average 1 hr 30 mins in group I and 2 hr 45 mins in group II. None of patients complained awareness during operations. Above results demonstrate that Nalbuphine-Diazepam-O2-1/2 MAC Halothane can be a anesthetic method for open heart surgery without any significant cardiovascular responses at surgical and anesthetic stimuli except intubation stimulus, but for more evaluation study of Nalbuphine-Diazepam-O2 Anesthesia will be needed.
Adult*
;
Anesthesia
;
Anesthesia, General*
;
Anesthetics
;
Blood Pressure
;
Consciousness
;
Diazepam*
;
Halothane*
;
Heart Defects, Congenital
;
Heart*
;
Humans
;
Hypertension
;
Inhalation
;
Intubation
;
Intubation, Intratracheal
;
Muscle Relaxation
;
Nalbuphine*
;
Research Personnel
;
Respiratory Insufficiency
;
Skin
;
Sodium
;
Sternotomy
;
Tachycardia
;
Thoracic Surgery*
;
Tricuspid Valve Insufficiency